BioHorizons Camlog launches Striate+ – a collagen membrane at the cutting-edge of performance
The combination of superior handling, optimal durability, apparent osteoconductivity, and enhanced clinical outcomes makes Striate+ a collagen membrane of choice for guided bone and tissue regeneration.
BioHorizons Camlog announced the launch of Striate+, an innovative collagen membrane developed by Orthocell Ltd. for advanced bone and tissue regeneration. BioHorizons Camlog and Orthocell Ltd have entered into a global distribution and manufacturing agreement for Striate+. The product strengthens BioHorizons Camlog’s position as a global provider of regenerative solutions for implant dentistry and covers the needs of a large portion of clinicians currently looking to improve the outcomes of their surgical procedures. Striate+ is exclusively available from BioHorizons Camlog.
Striate+ is manufactured from porcine-derived raw materials, selectively sourced from Australian veterinary-certified animals. The manufacturing process referred to as Scaffold Matrix Regenerative Therapy (SMRT™), removes immunogenic contaminants and ensures high biocompatibility while preserving the structure of the native collagen. The absence of any chemical modification or crosslinking promotes the integration of Striate+ with the surrounding soft tissues and can help minimise the risk of wound dehiscence. Striate+ is fully resorbed through physiological processes within 26 weeks, so a second surgical intervention to remove Striate+ is not necessary.
Furthermore, Striate+ exhibited excellent handling and usability. It can be applied without prior hydration and will gently conform and adhere to the defect contours without fixation yet can be stabilised by suturing and pinning if needed. A recent comparative study demonstrated that Striate+ had a higher mechanical strength than a leading competitor product (1). The membrane absorbs fluids by capillarity but doesn’t excessively swell, which facilitates the primary closure and makes it particularly suitable for patients with thin phenotypes.
Striate+ has a bilayer structure with a rough and a smooth side. The smooth side, comprising of densely packed collagen fibers, acts as a barrier to the infiltration of gingival cells while allowing the passage of bioactive molecules (1). Conversely, the rough side, composed of loosely distributed collagen fibers, provides a scaffold for osteoprogenitor cells to deposit osteoid. This results in an active promotion of bone formation and allows for early implant placement.
